1st Jun 2007 10:41
GlaxoSmithKline PLC01 June 2007 Total Voting Rights and Capital as at 31 May 2007 In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc("the Company") hereby notifies the market of the following: The Company's issued share capital as at 31 May 2007 consisted of 6,020,593,449Ordinary shares of 25p each with voting rights, of which 303,069,158 Ordinaryshares are held in Treasury. Therefore, the total number of voting rights in the Company is 5,717,524,291.This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to their interest in, the Company under the Financial ServicesAuthority's Disclosure and Transparency Rules. S M Bicknell Company Secretary 1 June 2007 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline